Insiders Cellectis S.A.

Equities

ALCLS

FR0010425595

Market Closed - Euronext Paris Other stock markets 11:35:03 2024-05-15 am EDT			After market 03:02:59 pm
2.76 ^EUR	+1.66%		2.755	-0.18%

May. 13	European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher	MT
May. 10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cellectis CFO Bing Wang Retires, Interim CFO Appointed	May. 03	MT
Cellectis S.A. Announces Board Appointments	Dec. 22	CI
Cellectis S.A. Announces Board Changes	23-06-29	CI
Cellectis S.A. Announces the Resignation of Alain Godard as a Member of the Board	23-01-04	CI
Biopharmaceutical Group Cellectis Hires Chief Medical Officer	22-09-29	MT
Cellectis Promotes Mark Frattini to Chief Medical Officer	22-09-28	MT
Cellectis Appoints Mark Frattini as Chief Medical Officer	22-09-28	CI
Zentalis Pharmaceuticals Hires Carrie Brownstein as Chief Medical Officer	22-09-19	MT
Cellectis S.A. Announces Executive Changes	22-08-04	CI
Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors	22-06-28	CI
Cellectis Names Bing Wang Finance Chief	22-02-11	MT
Cellectis Appoints CFO	22-02-10	MT
Cellectis Appoints Bing C. Wang as Member of its Executive Committee	22-02-10	CI
Cellectis Appoints Bing Wang as Chief Financial Officer	22-02-10	CI
Cellectis S.A. Announces Executive Changes	21-11-24	CI
Cellectis S.A. Announces Resignation of Eric Dutang as Chief Financial Officer, Effective January 3, 2022	21-11-24	CI
Cellectis Appoints Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer	20-11-16	CI
Cellectis S.A. Appoints Jean-Pierre Garnier, Ph.D as Non-Executive Chairman of the Board of Directors	20-11-05	CI
Cellectis Appoints Steve Doares as Senior Vice President of US Manufacturing	20-07-21	CI
Cellectis : To Fully Focus on Cellectis, Dr. AndrÃ© Choulika Retires From Calyxt's Board of Directors; Dr. Yves Ribeill, Member of Calyxt's Board of Directors since 2018, Appointed Chairman of the Board	20-07-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cellectis S.A.

Equities

ALCLS

FR0010425595

Insiders

Filters